Category: Company News
-

Alector Signs $1.27 Billion Genentech License Agreement for Parkinson’s Disease Program
Alector will receive $100 million upfront and could earn up to $1.17 billion in additional milestones while Genentech assumes responsibility for developing and commercializing AL050 globally. Key Investor Takeaways Why ALEC Stock Is in Focus Alector has entered an exclusive global licensing agreement with Genentech covering AL050, a preclinical brain-penetrant engineered glucocerebrosidase, or GCase, enzyme…
-

Neighborhood Intelligence and Fathom Holdings Terminate Proposed Merger Over Valuation
The companies will remain independent after their boards concluded current valuations did not reflect fair value, while Neighborhood Intelligence will retain its blockchain assets and both sides explore strategic collaboration. Key Investor Takeaways Why NXH and FTHM Stocks Are in Focus Neighborhood Intelligence and Fathom Holdings have abandoned their previously announced merger after their respective…
-

Alset AI Highlights FingerMotion Alberta Infrastructure Agreement and Lyken AI Strategic Alignment
Alset’s 2.2% FingerMotion stake and controlling interest in Lyken create exposure to the planned Alberta infrastructure project, although no compute capacity, customer revenue or commercial participation has yet been secured. Key Investor Takeaways Why GPUSF Stock Is in Focus Alset AI is highlighting the strategic connection between its investment in FingerMotion and its controlling ownership…
-

Stardust Power Opens Houston Office to Support Muskogee Lithium Refinery Build
The new project execution hub expands Stardust Power’s operational footprint as it advances plans for a U.S. battery-grade lithium carbonate refinery with capacity of up to 50,000 metric tons annually. Key Investor Takeaways Why SDST Stock Is in Focus Stardust Power has established a new Houston office that will serve as a project execution hub…
-

Cyabra Wins FBI OSINT Contract Positions for AI Image and Video Analysis
Cyabra can compete for FBI task orders through September 2031, creating a new route for its visual AI technology into U.S. federal investigations without guaranteeing contract revenue. Key Investor Takeaways Why CYAB Stock Is in Focus Cyabra’s wholly owned subsidiary, Cyabra Strategy, has been selected for two categories of the FBI’s Specialized Open-Source Intelligence Tools…
-

Bitmine Immersion Technologies ETH Holdings Reach 6.02 Million Tokens, Nearing 5% Supply Target
Bitmine’s Ethereum treasury now represents 4.9% of total ETH supply, while more than 5 million tokens are staked and the company puts annualized staking revenue at $363 million. Key Investor Takeaways Why BMNR Stock Is in Focus Bitmine’s ETH holdings have reached 6.02 million tokens just 15 months after the company began its Ethereum treasury…
-

Natera Launches Phase III MRD-Guided Breast Cancer Trial Using Signatera
AFT-70 NAVIGATE will test whether Signatera-guided treatment can reduce unnecessary CDK4/6 inhibitor exposure while maintaining outcomes in more than 2,000 patients. Key Investor Takeaways Why NTRA Stock Is in Focus Alliance Foundation Trials has launched AFT-70 NAVIGATE, a randomized Phase III study evaluating an MRD-guided treatment approach in patients with intermediate- and high-risk ER-positive/HER2-negative early…
-

Infineon Opens Bangkok Semiconductor Manufacturing Hub With Capacity for Major Expansion
The new Thailand backend manufacturing site can expand to five modules and is expected to employ around 1,000 people as its first production building ramps up. Key Investor Takeaways Why IFNNY Stock Is in Focus Infineon has officially opened its new backend semiconductor manufacturing hub in Bangkok, adding production capacity in Southeast Asia while further…
-

Medical Care Technologies Targets Agriculture Market With StrainScan Pro AI Vision Platform
StrainScan Pro is being configured to identify visible crop disease, ripeness, pest damage and other field anomalies as Medical Care Technologies works toward its first enterprise customers. Key Investor Takeaways Why MDCE Stock Is in Focus Medical Care Technologies is expanding the commercial positioning of StrainScan Pro by detailing an agricultural configuration designed to analyse…
-

HydroGraph to Showcase Fractal Graphene Paste Following Commercial Launch
HydroGraph will present its 20%-by-weight Fractal Graphene Paste at The Advanced Materials Show USA as it works to convert more than 30 customer evaluations into broader commercial adoption. Key Investor Takeaways Why HGRAF Stock Is in Focus HydroGraph is moving its recently launched Fractal Graphene Paste into the industry demonstration stage, with the company scheduled…